Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 10, 2007, Pages 1662-1665

  Hong, Su Jin ^a   Ko, Bong Min ^a   Jung, In Seop ^a   Ryu, Chang Beom ^a   Moon, Jong Ho ^a   Cho, Joo Young ^a   Kim, Jin Oh ^a   Lee, Joon Seong ^a   Lee, Moon Sung ^a   Shim, Chan Sup ^a   Kim, Boo Sung ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Acid sensitization; Ineffective esophageal motility; Reflux symptoms

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ESOPHAGEAL MOTOR DISORDER; ESOPHAGUS DISEASE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION;

EID: 34548527350     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04987.x     Document Type: Article

References (24)

1. Shi G, Bruley des Varannes S, Scarpignato C, le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995 37 : 457 64.
2. Lind T, Havelund T, Carlsson R et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand. J. Gastroenterol. 1997 32 : 974 9.
3. Holloway RH. The anti-reflux barrier and mechanisms of gastro-oesophageal reflux. Baillieres Best Pract. Res. Clin. Gastroenterol. 2000 14 : 681 99.
4. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment. Pharmacol. Ther. 2003 17 : 537 45.
5. Richter JE, Kovacs TO, Greski-Rose PA, Huangs B, Fisher R. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment. Pharmacol. Ther. 1999 13 : 795 804.
6. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995 37 : 7 12.
7. Marrero JM, Caestecker JS, Maxwell JD. Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease. Gut 1994 35 : 447 50.
8. Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am. J. Gastroenterol. 1999 94 : 1464 7.
9. Leite LP, Johnston BT, Barrett J, Castell JA, Castell DO. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig. Dis. Sci. 1997 42 : 1859 65.
10. Vinjirayer E, Gonzales B, Brensinger C et al. Ineffective motility is not a marker for gastroesophageal reflux disease. Am. J. Gastroenterol. 2003 98 : 771 6.
11. Kim SH, Lee JS, Im HH et al. The relationship between ineffective esophageal motility and gastroesophageal reflux disease. Korean J. Gastroenterol. 2005 46 : 255 61.
12. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001 49 : 145 51.
13. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 45 : 172 180.
14. Drossman DA, Corazziari R, Talley NJ et al. Rome II. The functional esophageal disorders. In : Drossman DA, ed. Rome II, 2nd edn. Lawrence, KS : Allen Press, 2000 275 278.
15. Youn YH, Kang YW, Ahn SH, Park SK. Prevalence alteration of reflux esophagitis in recent years. Korean J. Gastrointest. Endosc. 2001 23 : 144 8.
16. Jung SA, Jung HY, Kim KR, Min YI. The prevalence of reflux esophagitis of Korean adults for 10 years of 1990s. Korean J. Gastrointest. Motil. 2001 7 : 161 7.
17. Miwa H, Minoo T, Hojo M et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment. Pharmacol. Ther. 2004 20 (Suppl. 1 S112 17.
18. Mishima I, Adachi K, Arima N et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand. J. Gastroenterol. 2005 40 : 1005 9.
19. Diener U, Patti MG, Molena D, Fisichella PM, Way LW. Esophageal dysmotility and gastroesophageal reflux disease. J. Gastrointest. Surg. 2001 5 : 260 5.
20. Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986 91 : 897 904.
21. Williams D, Thompson DG, Heggie L, O'Hanrahan T, Bancewicz J. Esophageal clearance function following treatment of esophagitis. Gastroenterology 1994 106 : 108 16.
22. Fass J, Silny J, Braun J et al. Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients. Scand. J. Gastroenterol. 1994 29 : 693 702.
23. Nguyen HN, Silny J, Wuller S, Marschall HU, Rau G, Matern S. Chyme transport patterns in human duodenum, determined by multiple intraluminal impedancometry. Am. J. Physiol. 1995 268 : G700 8.
24. Tutuian R, Castell DO. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am. J. Gastroenterol. 2004 99 : 1011 19.